BTAI   $1.09  -4.39% Market Open

BioXcel Therapeutics, Inc.
Total Cash 56.27M
totalCashPerShare 1.381
EBITDA -104.30M
Total Debt 103.62M
quickRatio 2.092
currentRatio 2.352
Total Revenue 2.40M
debtToEquity
Revenue/Share 0.074
ROA -0.63622004
ROE
grossProfits
freeCashflow -65.60M
operatingCashflow -105.33M
earningsGrowth
revenueGrowth 1.416
grossMargins 0.43113
ebitdaMargins 0.0
operatingMargins -14.8913
profitMargins 0.0
enterpriseValue 74.93M
forwardPE -0.43975905
floatShares 29.66M
sharesOutstanding 40.74M
sharesShort 576.41K
sharesShortPriorMonth 697.63K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.20%
heldPercentInstitutions 0.22%
Short Ratio help_outline 0.89%
shortPercentOfFloat 0.02%
impliedSharesOutstanding
bookValue -1.84
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -107.83M
trailingEps -3.46%
forwardEps -1.66%
enterpriseToEbitda -0.72
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.54 3Q 2024
institutionsCount 93
lastUpdated Nov. 7, 2024, 2:48 a.m.